Genome-Wide Identification and Analysis of Enhancer-Regulated microRNAs Across 31 Human Cancers

Area of Science:

• Genomics
• Molecular Biology
• Cancer Research

Background:

• Enhancers are DNA elements regulating gene transcription, often tissue-specifically.
• Dysregulated gene expression contributes to diseases like cancer.
• Enhancers can regulate microRNAs (miRNAs), but the full network across cancers is unknown.

Purpose of the Study:

• To identify and characterize enhancer-miRNA interactions across 31 cancer types.
• To investigate the tissue-specific nature of these interactions.
• To explore the relationship between enhancer characteristics, miRNA expression, and cancer.

Main Methods:

• Integrated genomic distance, co-expression, and 3D genome data to identify enhancer-miRNA interactions.
• Analyzed 2,418 proximal and 1,280 distal interactions in 31 cancers.
• Examined sequence conservation, GC content, and histone modifications (H3K4me1, H3K36me3) of regulatory elements.

Main Results:

• Identified significant cancer type-specific trends in enhancer-miRNA interactions at the tissue level.
• Found a positive correlation between miRNA expression and the number of regulating enhancers.
• Observed a strong link between enhancer-miRNA pair formation and enhancer RNA (eRNA) expression.
• Differentiated enhancer characteristics (miRes vs. non-miRes) based on sequence conservation, GC content, and histone marks.

Conclusions:

• Enhancer-miRNA networks exhibit cancer-specific regulatory patterns.
• Epigenetic features like GC content and histone modifications are associated with enhancer-miRNA interactions and may influence 3D genome structure.
• A specific enhancer-miR-200a interaction is linked to thyroid cancer patient survival, with an eQTL SNP affecting tumor suppressor gene expression.